IP Library Granted Patent US 6,900,333
Granted Patent B2
US 6,900,333 · App. 10/733,565 · Granted May 31, 2005

Process for the preparation of 1, 2-dichlorethane free crystals of zonisamide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,333
App. No.
10/733,565
Granted
May 31, 2005
Kind
B2
Abstract

A process for the preparation of crystals of zonisamide containing residual 1,2-dichloroethane of not more than 5 ppm, by adding an aqueous C 2-4 alcohol to crystals of zonisamide containing residual 1,2-dichloroethane of more than 5 ppm, removing the 1,2-dichloroethane by azeotropic distillation, followed by collecting the precipitated crystals from the residual mixture.

Claims (15)

1. A process for the preparation of crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of not more than 5 ppm, which comprises adding an aqueous C 2-4 alcohol to crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of more than 5 ppm, removing said 1,2-dichloroethane by azeotropic distillation to obtain a residual mixture, followed by collecting precipitated crystals of 1,2-benzisoxazole-3-methanesulfonamide containing not more than 5 ppm of 1,2-dichloroethane from the residual mixture.

2. A process for the preparation of crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of not more than 5 ppm, which comprises:

(a) dissolving crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of more than 5 ppm in an aqueous C 2-4 alcohol, and subjecting the resultant mixture to azeotropic distillation;

(b) stopping the distillation after the azeotropic distillation of said 1,2-dichloroethane is completed to obtain a residual mixture;

(c) cooling the residual mixture to precipitate crystals of 1,2-benzisoxazole-3-methanesulfonamide containing not more than 5 ppm of 1,2-dichloroethane; and

(d) collecting the precipitated crystals of 1,2-benzisoxazole-3-methanesulfonamide by filtration and drying thereof.

3. A process for the preparation of crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of not more than 5 ppm, which comprises:

(a) dissolving crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of more than 5 ppm in an aqueous C 2-4 alcohol, and subjecting the resultant mixture to azeotropic distillation;

(b) stopping the distillation after the azeotropic distillation of said 1,2-dichloroethane is completed to obtain a residual mixture;

(c1) adding the same C 2-4 alcohol as used in (a) and/or water to the residual mixture obtained in (b), dissolving the residual mixture with heating, and cooling thereof to precipitate crystals of 1,2-benzisoxazole-3-methanesulfonamide containing not more than 5 ppm of 1,2-dichloroethane; and

(d1) collecting the precipitated crystals of 1,2-benzisoxazole-3-methanesulfonamide by filtration and drying thereof.

4. The process according to claim 1 , wherein the aqueous C 2-4 alcohol is an aqueous isopropanol.

5. The process according to claim 1 , wherein the aqueous C 2-4 alcohol is isopropanol containing water in an amount of 35 to 65% by volume.

6. The process according to claim 2 , wherein the temperature at which the distillation is stopped is in the range of from 78° C. to 100° C.

7. A process for the preparation of crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of not more than 5 ppm, which comprises adding an aqueous C 2-4 alcohol to crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of more than 5 ppm and distilling the resulting mixture, to remove at least some of the residual 1,2-dichloroethane from the crystals of 1,2-benzisoxazole-3-methanesulfonamide containing residual 1,2-dichloroethane of more than 5 ppm.

Assignments (3)
CHANGE OF NAME Recorded Jun 14, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 060188/0824 →
CHANGE OF NAME Recorded Dec 1, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034353/0558 →
CHANGE OF NAME Recorded Feb 3, 2006
From: DAINIPPON PHARMACEUTICAL CO., LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017546/0720 →